Agile Therapeutics, Inc. Share-based Payment Arrangement, Expense
Agile Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $284.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-08-12
- Agile Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $284.00K, a 41.08% decline year-over-year.
- Agile Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $333.00K, a 33.13% decline year-over-year.
- Agile Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $482.00K, a 27.95% decline year-over-year.
- Agile Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $498.00K, a 34.82% decline year-over-year.
- Agile Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2014 was $1.38M, a 3.20% increase from fiscal 2013.
- Agile Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2013 was $1.34M, a 101.04% increase from fiscal 2012.
- Agile Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2012 was $665.45K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $284.00K 10-Q · filed 2024-08-12 | $618.00K 10-Q · filed 2024-08-12 | ||
| 2024-03-31 | $333.00K 10-Q · filed 2024-05-15 | |||
| 2023-06-30 | $482.00K 10-Q · filed 2024-08-12 | $979.00K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $498.00K 10-Q · filed 2024-05-15 | |||
| 2022-09-30 | $536.00K 10-Q · filed 2022-11-07 | $1.21M derived: sum of 2 quarters · filed 2022-11-07 | $1.97M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $669.00K 10-Q · filed 2022-08-11 | $1.43M 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $764.00K 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | $887.00K 10-Q · filed 2022-11-07 | $1.73M derived: sum of 2 quarters · filed 2022-11-07 | $2.47M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $843.00K 10-Q · filed 2022-08-11 | $1.58M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $742.00K 10-Q · filed 2022-05-12 | |||
| 2020-09-30 | $647.00K 10-Q/A · filed 2021-12-30 | $1.49M derived: sum of 2 quarters · filed 2021-12-30 | $2.11M 10-Q/A · filed 2021-12-30 | |
| 2020-06-30 | $839.00K 10-Q · filed 2021-07-26 | $1.46M 10-Q · filed 2021-07-26 | ||
| 2020-03-31 | $621.00K 10-Q · filed 2021-05-04 | |||
| 2019-09-30 | $378.00K 10-Q · filed 2020-11-12 | $857.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.35M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $479.00K 10-Q · filed 2020-08-11 | $969.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $490.00K 10-Q · filed 2020-05-05 | |||
| 2018-09-30 | $721.00K 10-Q · filed 2019-10-28 | $1.71M derived: sum of 2 quarters · filed 2019-10-28 | $2.83M 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $987.00K 10-Q · filed 2019-08-01 | $2.11M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $1.12M 10-Q · filed 2019-05-03 | |||
| 2017-09-30 | $967.00K 10-Q · filed 2018-11-02 | $1.89M derived: sum of 2 quarters · filed 2018-11-02 | $2.73M 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $925.00K 10-Q · filed 2018-08-03 | $1.76M 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $835.00K 10-Q · filed 2018-05-07 | |||
| 2016-09-30 | $940.00K 10-Q · filed 2017-11-06 | $1.90M derived: sum of 2 quarters · filed 2017-11-06 | $2.61M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $955.00K 10-Q · filed 2017-07-28 | $1.67M 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | $711.00K 10-Q · filed 2017-05-08 | |||
| 2015-09-30 | $746.00K 10-Q · filed 2016-11-07 | $1.48M derived: sum of 2 quarters · filed 2016-11-07 | $2.13M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $738.00K 10-Q · filed 2016-08-08 | $1.38M 10-Q · filed 2016-08-08 | ||
| 2014-12-31 | $1.38M 10-K · filed 2015-03-26 | |||
| 2013-12-31 | $1.34M 10-K · filed 2015-03-26 | |||
| 2012-12-31 | $665.45K 10-K · filed 2015-03-26 |